Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE. (2021)

First Author: Pearson AD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2021.01.018

PubMed Identifier: 33601323

Publication URI: http://europepmc.org/abstract/MED/33601323

Type: Journal Article/Review

Volume: 146

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049